[1]
Gan, W.L., Mustafar, R., Kamaruzaman, L., Mohd, R., Cader, R.A., Kong, W.Y. and Pau, K.B. 2018. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis. Acta Medica Indonesiana. 50, 3 (Oct. 2018), 237.